Phase II study of pegylated liposomal doxorubicin (PLD) and carboplatin (Cb) can be administered with trastuzumab (H) in patients with metastatic breast cancer.
2005 ◽
Vol 23
(16_suppl)
◽
pp. 844-844
◽
2006 ◽
Vol 42
(7)
◽
pp. 882-887
◽
2005 ◽
Vol 57
(5)
◽
pp. 615-623
◽
2004 ◽
Vol 22
(14_suppl)
◽
pp. 813-813
◽
2008 ◽
Vol 98
(12)
◽
pp. 1916-1921
◽